Detalhe da pesquisa
1.
The MOTION study: a randomized, phase III study of vimseltinib for the treatment of tenosynovial giant cell tumor.
Future Oncol
; 20(10): 593-601, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37593881
2.
A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent ß-Thalassemia.
N Engl J Med
; 382(13): 1219-1231, 2020 03 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-32212518
3.
Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes.
N Engl J Med
; 382(2): 140-151, 2020 01 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31914241
4.
Clinical Benefit of Ripretinib Dose Escalation After Disease Progression in Advanced Gastrointestinal Stromal Tumor: An Analysis of the INVICTUS Study.
Oncologist
; 26(11): e2053-e2060, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34313371
5.
Luspatercept improves hemoglobin levels and blood transfusion requirements in a study of patients with ß-thalassemia.
Blood
; 133(12): 1279-1289, 2019 03 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-30617198
6.
A phase 2, randomized trial evaluating the combination of dalantercept plus axitinib in patients with advanced clear cell renal cell carcinoma.
Cancer
; 125(14): 2400-2408, 2019 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30951193
7.
A Phase Ib, Open-Label Study of Dalantercept, an Activin Receptor-Like Kinase 1 Ligand Trap, plus Sorafenib in Advanced Hepatocellular Carcinoma.
Oncologist
; 24(2): 161-e70, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30352941
8.
Locally acting ACE-083 increases muscle volume in healthy volunteers.
Muscle Nerve
; 57(6): 921-926, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29486514
9.
Luspatercept for the treatment of anaemia in patients with lower-risk myelodysplastic syndromes (PACE-MDS): a multicentre, open-label phase 2 dose-finding study with long-term extension study.
Lancet Oncol
; 18(10): 1338-1347, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28870615
10.
Myostatin inhibitor ACE-031 treatment of ambulatory boys with Duchenne muscular dystrophy: Results of a randomized, placebo-controlled clinical trial.
Muscle Nerve
; 55(4): 458-464, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27462804
11.
A phase 2 study of dalantercept, an activin receptor-like kinase-1 ligand trap, in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
Cancer
; 122(23): 3641-3649, 2016 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27648727
12.
Sotatercept (ACE-011) for the treatment of chemotherapy-induced anemia in patients with metastatic breast cancer or advanced or metastatic solid tumors treated with platinum-based chemotherapeutic regimens: results from two phase 2 studies.
Support Care Cancer
; 24(4): 1517-25, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26370220
13.
Sotatercept in patients with osteolytic lesions of multiple myeloma.
Br J Haematol
; 165(6): 814-23, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24650009
14.
A phase 1 study of ACE-536, a regulator of erythroid differentiation, in healthy volunteers.
Am J Hematol
; 89(7): 766-70, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24715706
15.
Ripretinib versus sunitinib in gastrointestinal stromal tumor: ctDNA biomarker analysis of the phase 3 INTRIGUE trial.
Nat Med
; 30(2): 498-506, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38182785
16.
A single ascending-dose study of muscle regulator ACE-031 in healthy volunteers.
Muscle Nerve
; 47(3): 416-23, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23169607
17.
Patient-reported outcomes and tolerability in patients receiving ripretinib versus sunitinib after treatment with imatinib in INTRIGUE, a phase 3, open-label study.
Eur J Cancer
; 192: 113245, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37598656
18.
Ripretinib Versus Sunitinib in Patients With Advanced Gastrointestinal Stromal Tumor After Treatment With Imatinib (INTRIGUE): A Randomized, Open-Label, Phase III Trial.
J Clin Oncol
; 40(34): 3918-3928, 2022 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35947817
19.
Sotatercept Safety and Effects on Hemoglobin, Bone, and Vascular Calcification.
Kidney Int Rep
; 4(11): 1585-1597, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31891000
20.
Phase I clinical trial of STA-4783 in combination with paclitaxel in patients with refractory solid tumors.
Clin Cancer Res
; 13(2 Pt 1): 584-90, 2007 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17255281